Loading viewer...
investor_presentation
Format: PDF investor_presentation
Azul investor presentation dated August 2021.
2Q21 Earnings Results
August 12, 20212DISCLAIMER
Theinformation contained inthispresentation isonly asummary and does notpurport tobecomplete .This presentation hasbeen prepared solely forinformational purposes and should notbe
construed asfinancial, legal, tax,accounting, investment orother advice orarecommendation with respect toanyinvestment .Thispresentation does notconstitute orform part ofanyoffer orinvitation
forsaleorsubscription oforsolicitation orinvitation ofanyoffer tobuyorsubscribe foranysecurities, norshall itoranypart ofitform thebasis oforberelied oninconnection with anycontract or
commitment whatsoever .
This presentation includes estimates andforward -looking statements within themeaning oftheU.S.federal securities laws.These estimates andforward -looking statements arebased mainly onour
current expectations andestimates offuture events andtrends that affect ormay affect ourbusiness, financial condition, results ofoperations, cash flow, liquidity, prospects andthetrading price ofour
preferred shares, including intheform ofADSs .Although webelieve that these estimates andforward -looking statements arebased upon reasonable assumptions, they aresubject tomany significant
risks, uncertainties andassumptions andaremade inlight ofinformation currently available tous.
These statements appear throughout thispresentation andinclude statements regarding ourintent, belief orcurrent expectations inconnection with:changes inmarket prices, customer demand and
preferences andcompetitive conditions ;general economic, political andbusiness conditions inBrazil, particularly inthegeographic markets weserve aswellasanyother countries wecurrently serve and
may serve inthefuture ;ourability tokeep costs low;existing andfuture governmental regulations ;increases inmaintenance costs, fuelcosts andinsurance premiums ;ourability tomaintain landing
rights intheairports that weoperate ;airtravel substitutes ;labor disputes, employee strikes andother labor -related disruptions, including inconnection with negotiations with unions ;ourability to
attract andretain qualified personnel ;ouraircraft utilization rate;defects ormechanical problems with ouraircraft ;ourability tosuccessfully implement ourgrowth strategy, including ourexpected fleet
growth, passenger growth, ourcapital expenditure plans, ourfuture joint venture and partnership plans, ourability toenter new airports (including certain international airports), that match our
operating criteria ;management’s expectations andestimates concerning ourfuture financial performance andfinancing plans andprograms ;ourlevel ofdebt andother fixed obligations ;ourreliance on
third parties, including changes intheavailability orincreased cost ofairtransport infrastructure andairport facilities ;inflation, appreciation, depreciation anddevaluation ofthereal;ouraircraft and
Preview truncated — download the full document for the complete content.
investor_presentation
23 Pages
Archean Chemical Industries Limited
Zentalis Pharmaceuticals Investor Presentation — June 2022
investor_presentationinvestor_presentation
56 Pages
Zentalis Pharmaceuticals, Inc.